 Matinas BioPharma Holdings, Inc. NYSE:MTNB Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Ankit Bhargava - Investor Relations Jerry Jabbour - Chief Executive Officer Terry Matkovits - Chief Development Officer Terry Ferguson - Chief Medical Officer Keith Kucinski - Chief Financial Officer Thomas Hoover - Chief Business Officer Conference Call Participants Greg Fraser - Truist Robert Hazlett - BTIG Sahil Kazmi - B. Riley Securities Operator Welcome to the Matinas BioPharma Third Quarter 2022 Results Conference Call. 